000 01540 a2200433 4500
005 20250518095131.0
264 0 _c20210616
008 202106s 0 0 eng d
022 _a2373-8227
024 7 _a10.1021/acsinfecdis.9b00505
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTunes, Luiza G
245 0 0 _aPreclinical Gold Complexes as Oral Drug Candidates to Treat Leishmaniasis Are Potent Trypanothione Reductase Inhibitors.
_h[electronic resource]
260 _bACS infectious diseases
_c05 2020
300 _a1121-1139 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntiprotozoal Agents
_xpharmacology
650 0 4 _aGold
_xpharmacology
650 0 4 _aLeishmaniasis
_xdrug therapy
650 0 4 _aMice
650 0 4 _aMice, Inbred BALB C
650 0 4 _aNADH, NADPH Oxidoreductases
_xantagonists & inhibitors
650 0 4 _aOxidative Stress
700 1 _aMorato, Roberta E
700 1 _aGarcia, Adriana
700 1 _aSchmitz, Vinicius
700 1 _aSteindel, Mario
700 1 _aCorrêa-Junior, José D
700 1 _aDos Santos, Hélio F
700 1 _aFrézard, Frédéric
700 1 _ade Almeida, Mauro V
700 1 _aSilva, Heveline
700 1 _aMoretti, Nilmar S
700 1 _ade Barros, André L B
700 1 _ado Monte-Neto, Rubens L
773 0 _tACS infectious diseases
_gvol. 6
_gno. 5
_gp. 1121-1139
856 4 0 _uhttps://doi.org/10.1021/acsinfecdis.9b00505
_zAvailable from publisher's website
999 _c30851074
_d30851074